GSK CEO Garnier says data will ‘vindicate’ Avandia
GlaxoSmithKline CEO Jean-Pierre Garnier said forthcoming Avandia safety data could help the drug regain sales it may potentially lose due to safety concerns currently swirling around the diabetes treatment.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.